Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 9033, USA.
Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 9033, USA.
Molecules. 2022 Sep 29;27(19):6430. doi: 10.3390/molecules27196430.
This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein-protein interactions remains challenging, as the interacting surfaces are relatively large and flat. However, highly constrained polypeptide-based molecular frameworks with cell-permeability properties, such as the cyclotide scaffold, have shown great promise for targeting those biomolecular interactions. The use of molecular techniques, such as epitope grafting and molecular evolution employing the cyclotide scaffold, has shown to be highly effective for selecting bioactive cyclotides.
这篇综述概述了环肽的特性及其在开发新型基于肽的治疗药物方面的潜力。选择性地破坏蛋白质-蛋白质相互作用仍然具有挑战性,因为相互作用的表面相对较大且平坦。然而,具有细胞通透性特性的高度约束多肽基分子框架,如环肽支架,已显示出针对这些生物分子相互作用的巨大潜力。使用分子技术,如表位嫁接和利用环肽支架进行分子进化,已被证明是选择生物活性环肽的非常有效的方法。